Ovarian cancer screening. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Cell Line, Tumor Tumor Cells, Cultured Ovary Neoplastic Stem Cells Epithelial Cells Breast Spheroids, Cellular Ascitic Fluid Epithelium

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases54

Ovarian Neoplasms Neoplasms, Glandular and Epithelial Cystadenocarcinoma, Serous Breast Neoplasms Carcinoma Neoplasm Invasiveness Adenocarcinoma, Clear Cell Carcinoma, Endometrioid Peritoneal Neoplasms Adenocarcinoma, Mucinous Genetic Predisposition to Disease Prostatic Neoplasms Neoplasm Metastasis Ascites Lung Neoplasms Neoplasms Colonic Neoplasms Stomach Neoplasms Cystadenocarcinoma Disease Progression Neoplasm Recurrence, Local Endometrial Neoplasms Pancreatic Neoplasms Fallopian Tube Neoplasms Neoplasms, Cystic, Mucinous, and Serous Uterine Cervical Neoplasms Neoplastic Syndromes, Hereditary Genital Neoplasms, Female Hereditary Breast and Ovarian Cancer Syndrome Cell Transformation, Neoplastic Colorectal Neoplasms Adenocarcinoma Cystadenocarcinoma, Mucinous Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Neovascularization, Pathologic Urinary Bladder Neoplasms Cystadenoma, Serous Rectal Neoplasms Adenocarcinoma, Papillary Breast Neoplasms, Male Neoplasms, Multiple Primary Neoplasms, Second Primary Esophageal Neoplasms Cystadenocarcinoma, Papillary Liver Neoplasms Neoplasms, Hormone-Dependent Precancerous Conditions Disease Models, Animal Head and Neck Neoplasms Carcinoma, Small Cell Mouth Neoplasms Ovarian Cysts Gastrointestinal Neoplasms

Chemicals and Drugs63

CA-125 Antigen Antineoplastic Agents Tumor Markers, Biological Cisplatin Paclitaxel BRCA2 Protein BRCA1 Protein Neoplasm Proteins Carboplatin Antineoplastic Agents, Phytogenic Epididymal Secretory Proteins RNA, Messenger Cancer Vaccines DNA, Neoplasm RNA, Small Interfering Antigens, Neoplasm Receptor, erbB-2 Platinum Compounds Tumor Suppressor Protein p53 Platinum Receptors, Estrogen Antibodies, Monoclonal Topotecan Antigens, Tumor-Associated, Carbohydrate Taxoids RNA, Neoplasm Transcription Factors MicroRNAs Tumor Suppressor Proteins Receptors, Progesterone Receptor, Epidermal Growth Factor Organoplatinum Compounds DNA-Binding Proteins Tamoxifen Altretamine Proto-Oncogene Proteins c-akt Contraceptives, Oral Prostate-Specific Antigen Fluorouracil Proto-Oncogene Proteins Nuclear Proteins Deoxycytidine Antineoplastic Agents, Hormonal Folate Receptor 1 Antibodies, Monoclonal, Humanized Anticarcinogenic Agents Mucin-1 Antimetabolites, Antineoplastic Estrogens Antibiotics, Antineoplastic GPI-Linked Proteins Antibodies, Neoplasm Vascular Endothelial Growth Factor A Talc Lysophospholipids DNA Primers Protein-Serine-Threonine Kinases Receptors, Androgen Membrane Proteins Protein Kinase Inhibitors Thymol Cyclophosphamide Bridged Compounds

Analytical, Diagnostic and Therapeutic Techniques and Equipment65

Early Detection of Cancer Neoplasm Staging Prognosis Antineoplastic Combined Chemotherapy Protocols Survival Analysis Xenograft Model Antitumor Assays Reverse Transcriptase Polymerase Chain Reaction Survival Rate Gene Expression Profiling Disease-Free Survival Risk Risk Factors Blotting, Western Neoplasm Transplantation Prospective Studies Retrospective Studies Follow-Up Studies Genetic Testing Immunohistochemistry Odds Ratio Transplantation, Heterologous Risk Assessment Combined Modality Therapy Oligonucleotide Array Sequence Analysis Sensitivity and Specificity Registries Kaplan-Meier Estimate Drug Screening Assays, Antitumor Tissue Array Analysis Case-Control Studies Multivariate Analysis Treatment Outcome Tumor Burden Polymerase Chain Reaction Neoplasm Grading Transfection Chemotherapy, Adjuvant Drug Administration Schedule DNA Mutational Analysis Questionnaires Gene Knockdown Techniques Molecular Targeted Therapy Predictive Value of Tests Incidence SEER Program Logistic Models Reproducibility of Results Confidence Intervals Flow Cytometry Salpingectomy Clinical Trials as Topic Immunoenzyme Techniques Cohort Studies Mammography Models, Biological Genetic Therapy Sterilization, Tubal Enzyme-Linked Immunosorbent Assay Ovariectomy Immunotherapy Reproductive History Disease Models, Animal Inhibitory Concentration 50 Pedigree Real-Time Polymerase Chain Reaction

Psychiatry and Psychology1

Phenomena and Processes51

Genes, BRCA1 Gene Expression Regulation, Neoplastic Drug Resistance, Neoplasm Genes, BRCA2 Genetic Predisposition to Disease Germ-Line Mutation Mutation Cell Proliferation Risk Apoptosis Cell Survival DNA Methylation Odds Ratio Sensitivity and Specificity Cell Movement Genotype Cell Growth Processes Down-Regulation Signal Transduction Cell Division Genes, Tumor Suppressor Up-Regulation Dose-Response Relationship, Drug Cell Cycle Transfection RNA Interference Polymorphism, Genetic Promoter Regions, Genetic Gene Silencing Heterozygote Drug Synergism Gene Expression Genes, Neoplasm Base Sequence Genes, p53 Alleles Postmenopause Loss of Heterozygosity Time Factors Phosphorylation Phenotype Tumor Microenvironment Parity Menopause Diet Epithelial-Mesenchymal Transition Gene Amplification Epigenesis, Genetic Inhibitory Concentration 50 DNA Repair CpG Islands

Disciplines and Occupations3

Immunohistochemistry Medical Oncology Genetic Counseling

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Humanities1

Quality of Life

Information Science7

Survival Rate Registries Questionnaires Incidence SEER Program Base Sequence Molecular Sequence Data

Named Groups3

Survivors Jews European Continental Ancestry Group

Health Care31

Survival Analysis Survival Rate Disease-Free Survival Risk Risk Factors Prospective Studies Retrospective Studies Follow-Up Studies Genetic Testing Odds Ratio Risk Assessment Sensitivity and Specificity Registries Kaplan-Meier Estimate Case-Control Studies Multivariate Analysis Treatment Outcome National Cancer Institute (U.S.)Questionnaires Predictive Value of Tests Incidence SEER Program Logistic Models Reproducibility of Results Confidence Intervals Clinical Trials as Topic Genetic Counseling Cohort Studies Family Health Parity Reproductive History

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Ovarian Neoplasms Neoplasms, Glandular and Epithelial CA-125 Antigen Cystadenocarcinoma, Serous Genes, BRCA1 Early Detection of Cancer Cell Line, Tumor Breast Neoplasms Gene Expression Regulation, Neoplastic Drug Resistance, Neoplasm Carcinoma Antineoplastic Agents Mice, Nude Tumor Markers, Biological Neoplasm Invasiveness Genes, BRCA2 Adenocarcinoma, Clear Cell Cisplatin Paclitaxel Neoplasm Staging BRCA2 Protein Carcinoma, Endometrioid Prognosis BRCA1 Protein Neoplasm Proteins Peritoneal Neoplasms Adenocarcinoma, Mucinous Genetic Predisposition to Disease Prostatic Neoplasms Neoplasm Metastasis Antineoplastic Combined Chemotherapy Protocols Survival Analysis Ascites Xenograft Model Antitumor Assays Lung Neoplasms Neoplasms Reverse Transcriptase Polymerase Chain Reaction Survival Rate Colonic Neoplasms Stomach Neoplasms Carboplatin Germ-Line Mutation Gene Expression Profiling Tumor Cells, Cultured Antineoplastic Agents, Phytogenic Mutation Epididymal Secretory Proteins Cell Proliferation Cystadenocarcinoma Disease Progression Neoplasm Recurrence, Local Disease-Free Survival RNA, Messenger Risk Endometrial Neoplasms Risk Factors Cancer Vaccines Pancreatic Neoplasms Fallopian Tube Neoplasms Apoptosis Blotting, Western DNA, Neoplasm Ovary RNA, Small Interfering Neoplasm Transplantation Prospective Studies Retrospective Studies Follow-Up Studies Genetic Testing Immunohistochemistry Cell Survival DNA Methylation Neoplasms, Cystic, Mucinous, and Serous Uterine Cervical Neoplasms Antigens, Neoplasm Odds Ratio Receptor, erbB-2 Platinum Compounds Tumor Suppressor Protein p53 Transplantation, Heterologous Risk Assessment Combined Modality Therapy Neoplastic Syndromes, Hereditary Oligonucleotide Array Sequence Analysis Sensitivity and Specificity Registries Genital Neoplasms, Female Platinum Cell Movement Kaplan-Meier Estimate Drug Screening Assays, Antitumor Hereditary Breast and Ovarian Cancer Syndrome United States Cell Transformation, Neoplastic Receptors, Estrogen Genotype Tissue Array Analysis Colorectal Neoplasms Cell Growth Processes Down-Regulation

No FAQ available that match "ovarian cancer screening"